Literature DB >> 519954

Lactoferrin turnover in man.

R M Bennett, T Kokocinski.   

Abstract

1. The turnover of 125I-labelled lactoferrin was measured in ten adults. Simultaneous organ radioactivity counting was performed. 2. Ferrokinetic studies were performed in three adults after the intravenous injection of [59Fe]lactoferrin. 3. Lactoferrin was rapidly eliminated from the plasma with a mean fractional catabolic rate of 5.7/day. Apolactoferrin (one subject) was eliminated at a slower rate (fractional catabolic rate 1.22/day). 4. Of the administered 125I label 99% was recovered in the urine, as free iodine, within the first 24 h. In the 59Fe studies no appreciable activity was found in the urine. 5. Organ radioactivity counting showed that lactoferrin was rapidly taken up by the liver and spleen. In the 125I studies the rapid excretion of free 125I suggested catabolism at these sites. In the 59Fe studies, the radioactivity persisted in the liver and spleen for several weeks and was slowly transferred to the bone marrow before appearing in circulating erythrocytes. 6. From the values of fractional catabolic rate, plasma lactoferrin, neutrophil lactoferrin and plasma volume, a 'derived neutrophil turnover' was calculated for each subject. The mean value was 8 x 10(8) neutrophils/day. This is about 1% the value obtained from the actual measurement of labelled cells. It is postulated that this 'derived value' represents only that portion of neutrophil turnover accounted for by intravascular senescence.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 519954     DOI: 10.1042/cs0570453

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  18 in total

1.  Sex-related differences in hematological values. A study on the erythrocyte and granulocyte count, plasma iron and iron-binding proteins in human transsexuals on contrasexual hormone therapy.

Authors:  A Rosenmund; H P Köchli; M P König
Journal:  Blut       Date:  1988-01

2.  Thalidomide inhibits granulocyte responses in healthy humans after ex vivo stimulation with bacterial antigens.

Authors:  N P Juffermans; A Verbon; M J Schultz; C E Hack; S J van Deventer; P Speelman; T van der Poll
Journal:  Antimicrob Agents Chemother       Date:  2001-05       Impact factor: 5.191

3.  Characterization of binding of human lactoferrin to pneumococcal surface protein A.

Authors:  A Håkansson; H Roche; S Mirza; L S McDaniel; A Brooks-Walter; D E Briles
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

4.  Isolated rat hepatocytes differentially bind and internalize bovine lactoferrin N- and C-lobes.

Authors:  M P Sitaram; D D McAbee
Journal:  Biochem J       Date:  1997-05-01       Impact factor: 3.857

5.  Lactoferrin binding to the rat asialoglycoprotein receptor requires the receptor's lectin properties.

Authors:  D D McAbee; X Jiang; K B Walsh
Journal:  Biochem J       Date:  2000-05-15       Impact factor: 3.857

6.  Lactoferrin is a natural inhibitor of plasminogen activation.

Authors:  Alexander Zwirzitz; Michael Reiter; Rostislav Skrabana; Anna Ohradanova-Repic; Otto Majdic; Marianna Gutekova; Ondrej Cehlar; Eva Petrovčíková; Eva Kutejova; Gerold Stanek; Hannes Stockinger; Vladimir Leksa
Journal:  J Biol Chem       Date:  2018-04-18       Impact factor: 5.157

7.  Effect of postponed treatment with an anti-tumour necrosis factor (TNF) F(ab')2 fragment on endotoxin-induced cytokine and neutrophil responses in chimpanzees.

Authors:  T van der Poll; M Levi; H ten Cate; J Jansen; B J Biemond; B L Haagmans; A Eerenberg; S J van Deventer; C E Hack; J W ten Cate
Journal:  Clin Exp Immunol       Date:  1995-04       Impact factor: 4.330

8.  Clearance and binding of native and defucosylated lactoferrin.

Authors:  M J Imber; S V Pizzo
Journal:  Biochem J       Date:  1983-05-15       Impact factor: 3.857

9.  Recognition of lactoferrin and aminopeptidase M-modified lactoferrin by the liver: involvement of proteoglycans and the remnant receptor.

Authors:  G J Ziere; J K Kruijt; M K Bijsterbosch; T J van Berkel
Journal:  Biochem J       Date:  1996-01-01       Impact factor: 3.857

10.  A possible role for lysozyme in determining acute exacerbation in chronic bronchitis.

Authors:  D C Taylor; A W Cripps; R L Clancy
Journal:  Clin Exp Immunol       Date:  1995-11       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.